HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.

AuthorsDeniz Peker, Antonio E Martinez, Michael A Schwartz, Mike Cusnir
JournalClinical advances in hematology & oncology : H&O (Clin Adv Hematol Oncol) Vol. 10 Issue 3 Pg. 204-6 (Mar 2012) ISSN: 1543-0790 [Print] United States
PMID22402431 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Doxorubicin
Topics
  • Adult
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Castleman Disease (complications, drug therapy)
  • Doxorubicin (administration & dosage)
  • HIV Infections (virology)
  • Herpesviridae Infections (complications)
  • Herpesvirus 8, Human
  • Humans
  • Male
  • Middle Aged
  • Remission Induction
  • Rituximab
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: